Publications 2025

Bjørkekjær HJ, Bruni C, Broch K, Brunborg C, Carreira PE, Airò P, Simeón-Aznar CP, Truchetet ME, Giollo A, Balbir-Gurman A, Martin M, Denton CP, Gabrielli A, Del Galdo F, Vonk MC, Fretheim H, Bitter H, Midtvedt Ø, Andreassen A, Høie S, Tanaka Y, Riemekasten G, Müller-Ladner U, Matucci-Cerinic M, Castellví I et al. (2025)
A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis
Rheumatology (Oxford), 64 (6), 3643-3656
DOI 10.1093/rheumatology/keaf053, PubMed 39878955

Bruni C, Tofani L, Fretheim H, Liem SIE, Velauthapillai A, Bjørkekjær H, Barua I, Galetti I, Garaiman A, Becker MO, Hoffmann-Vold AM, de Vries-Bouwstra J, Vonk MC, Distler JHW, Matucci-Cerinic M, Distler O (2025)
A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC Score
Rheumatology (Oxford) (in press)
DOI 10.1093/rheumatology/keaf445, PubMed 40811030

Hoffmann-Vold AM, Petelytska L, Fretheim H, Aaløkken TM, Becker MO, Jenssen Bjørkekjær H, Brunborg C, Bruni C, Clarenbach C, Diep PP, Dobrota R, Durheim MT, Elhai M, Frauenfelder T, Huang S, Jordan S, Langballe E, Midtvedt Ø, Mihai C, Mulcaire-Jones E, Pugashetti JV, Sprecher M, Oldham J, Molberg Ø, Khanna D et al. (2025)
Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study
Lancet Rheumatol, 7 (7), e463-e471
DOI 10.1016/S2665-9913(25)00026-8, PubMed 40381640

Publications 2024

Scheidegger M, Boubaya M, Garaiman A, Barua I, Becker M, Bjørkekjær HJ, Bruni C, Dobrota R, Fretheim H, Jordan S, Midtvedt O, Mihai C, Hoffmann-Vold AM, Distler O, Elhai M (2024)
Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort
RMD Open, 10 (1)
DOI 10.1136/rmdopen-2023-003658, PubMed 38199606